EFFECT OF YOGA ON AMBULATORY GLUCOSE PROFILE IN TYPE 2 DIABETES MELLITUS
Date
2019-01
Journal Title
Journal ISSN
Volume Title
Publisher
S-VYASA
Abstract
Management of diabetes and its complications are laying a huge burden in the
economy of developing nations like India, with the annual expenditure for the
management of diabetes accounting to US$ 727 billion, of which major portion is spent
on the direct and indirect costs related to the ‘complications’ of diabetes. There is
growing interest in alternative and holistic model of care which is evidence-based. Yoga
is a mind/body practise which is increasingly used in the management of many modern
non-communicable diseases (NCDs) including type 2 diabetes and its complications.
Glycemic variability is an emerging target for diabetes management, along with HbA1C
and plasma glucose levels. Glycemic variability is known to induce excessive oxidative
stress and is an independent risk factor for the complications of diabetes and increased
risk of mortality.
AIM AND OBJECTIVES
To study the effect of yoga on glycemic variability and mean daily glucose
levels in patients with type 2 diabetes in comparison to the active control group
(walking). The objectives were to study the effect of (i) Intraday variability (ii) Interday
variability and (iii) mean daily glucose levels.
METHODS
Participants
A total of 60 participants with diagnosed type 2 diabetes with HbA1C between
7% - 8.5% were recruited for the study from a private diabetes specialty hospital in
Chennai.Design
Participants were randomly assigned either to the intervention group or the
active control group of walking using a computer generated block randomisation, with
six participants per block. Allocation concealment was carried out using sequentially
numbered opaque sealed envelope (SNOSE), maintained by a person who was not
directly involved in the project.
Assessments
Continuous glucose monitoring (CGM) was carried out using flash glucose
monitoring system, Freestyle Libre Pro (Abbott Diabetes Care Ltd., Oxon, UK), applied
on the non-dominant backside upper arm of the participants, which measures glucose
levels every 15 minutes for a period of 14 days continuously. Of which, the first 7 days
were utilised for establishing baseline in the glycemic variability, while in the following
7 days, the participants underwent either yoga sessions or the control sessions. Data was
extracted using the EasyGV software to calculate various measures of glycemic
variability.
Intervention
During the experimental yoga sessions, a validated yoga module was taught for
duration of one hour including breathing practices, relaxation, asanas, pranayama and
meditation. Control group went for walking for a similar duration of one hour everyday
as well. Log book was maintained to know the adherence rate.
Data Analysis
Data analysis was done using statistical package for social sciences (SPSS)- version
24.0. Earlier glycemic variability was calculated using the EasyGV sotware (version
9.0) (www.phc.ox.ac.uk). RESULTS AND DISCUSSIONS
Of the 60 participants included in the study, 57 participants completed the study,
with three drop outs. After seven days of intervention, the mean daily glucose levels
reduced by 23.99 mg/dL (p<0.001) when compared to 8.69 mg/dL (p<0.05) in the
control group, with statistically insignificant difference between groups (p>0.05).
However, glycemic variability between groups was statistically significant in the
measures of intraday glycaemic variability, inter-day glycemic variability and also
overall glycemic variability.
CONCLUSION
Glycemic variability strongly correlates with β-cell dysfunction and yoga thus
might be helpful in better management of in β-cell dysfunction T2DM. The need for an
effective and cost-efficient treatment strategy in the secondary prevention of T2DM is
increasing. Future implications of yoga in the management of T2DM and preventing
complications of T2DM are very promising, with lesser risk of hypoglycaemia and
glycemic variability.
Description
Keywords
Yoga, Life style, Diabetes, Type 2 Diabetes, non-communicable diseases, plasma, glucose levels, Health